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Abstract  
 
This study investigated the impact of sleep deprivation on the human circadian system. 
Plasma melatonin and cortisol, and leukocyte expression levels of 12 genes were examined 
over 48 h (sleep vs no sleep nights) in 12 young males (mean ± SD, 23 ± 5 yrs). During one 
night of total sleep deprivation BMAL1 expression was suppressed, the heat shock gene 
HSPA1B expression was induced, and the amplitude of the melatonin rhythm increased while 
other high-amplitude clock gene rhythms (e.g. PER1-3, REV-ERB) remained unaffected. 
 Our data suggest that the core clock mechanism in peripheral oscillators is compromised 
during acute sleep deprivation. 
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Introduction 
 
In our modern 24/7 society, chronic partial sleep deprivation is becoming increasingly 
common. There is mounting evidence that long-term sleep deprivation has a severe impact on 
health and enhances vulnerability to both, infectious diseases and pathologies such as 
diabetes, obesity, or cancer (Lamont et al., 2007; Logan & Sarkar, 2012; Mullington et al., 
2010). Restricted sleep has been shown to significantly phase-delay the melatonin rhythm in 
humans, independent of bedtime (Burgess & Eastman, 2004; Burgess & Eastman, 2006). The 
acute impact of sleep deprivation on the circadian system, however, has not been fully 
elucidated in humans. As the circadian system controls most aspects of our daily lives, 
including cyclic changes in physiology, behaviour, and metabolism (Hastings et al., 2003; 
Mohawk et al., 2012), profiling of the central and peripheral clocks during sleep deprivation 
will be key to understanding the molecular basis of how these pathologies develop (Hastings 
et al., 2003; Kyriacou & Hastings, 2010; Lamont et al., 2007; Logan & Sarkar, 2012).  
 
In mammals, the core clock mechanism is based on a transcriptional-translational feedback 
loop involving the Period (PER) and Cryptochrome (CRY) genes as negative elements, the 
basic helix-loop-helix Per-Arnt-Sim (PAS) transcription factors CLOCK  and BMAL1  as 
positive components (Hastings et al., 2003; Isojima et al., 2003) and a range of auxiliary 
loops for stabilisation (Albrecht, 2012; Isojima et al., 2003; Relogio et al., 2011). While there 
are a number of reports on rhythmic expression of clock genes in human peripheral blood cell 
oscillators (Archer et al., 2008; Boivin et al., 2003; Fukuya et al., 2007; Kusanagi et al., 
2008), studies investigating changes in these rhythms upon sleep deprivation are fewer. A 
recent study provided some data on clock gene expression during sleep deprivation under 
light conditions compared to during sleep (Kavcic et al., 2011). The authors found significant 
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rhythmicity for BMAL1 expression under both conditions whereas rhythmicity in PER2 
expression was strongly affected by sleep deprivation. The study, however, was limited by a 
small number of subjects (n = 7), a blood sampling interval of 4 h, and restriction to the 
analysis of two genes (PER2 and BMAL1). An earlier study in six subjects described 
comparable rhythms for PER1 and PER2 under sleep/wake and constant routine sleep 
deprivation conditions, and a more variable expression for BMAL1, with differences in peak 
times between the two conditions (James et al., 2007). Studies in mice showed that 
cryptochromes may be involved in the homeostatic regulation of sleep, and that changes in 
the expression of clock-related genes in the cerebral cortex during sleep deprivation are 
strain-dependent and parallel the electroencephalographic response (Wisor et al., 2002; Wisor 
et al., 2008).  Using microarrays, a recent study showed that the number of brain transcripts 
affected by sleep deprivation, including some circadian genes, could be reduced by 
adrenalectomy (Mongrain et al., 2010). 
 Similarly, although melatonin and cortisol are two well-characterised central circadian clock-
controlled hormones, the effect of acute sleep deprivation on their rhythmicity (in terms of 
amplitude and timing) has provided conflicting results (Salin-Pascual et al., 1988; von Treuer 
et al., 1996; Zeitzer et al., 2007). While one study observed increased melatonin levels after 
sleep deprivation, cortisol levels remained unchanged, and no information was given on the 
timing of the melatonin rhythm (Salin-Pascual et al., 1988).   Another study described 
opposite results, with elevated cortisol and unchanged melatonin levels on the sleep 
deprivation night (von Treuer et al., 1996). A more recent study also reported elevated levels 
of melatonin during extended wakefulness (constant routine conditions) in young subjects, 
and an age-dependent difference in melatonin concentrations during sleep deprivation  
(Zeitzer et al., 2007).  
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The current study aimed to assess the impact of one night of total sleep deprivation under 
strictly controlled laboratory conditions on markers of both the central circadian pacemaker, 
located in the suprachiasmatic nuclei (SCN) of the hypothalamus, and peripheral blood cell 
oscillators. An in-depth characterisation of diurnal rhythms in expression levels of 11 clock 
genes (PER1-3, CRY1-2, BMAL1, CLOCK, DBP, DEC1, REV-ERB, RORA), a heat shock 
gene (HSPA1B) known to be involved in the oxidative stress response in peripheral 
leukocytes, and a comprehensive analysis of the circadian rhythms of plasma melatonin and 
cortisol was undertaken during a full 24 h sleep/wake cycle and a subsequent 24 h wake/wake 
cycle (i.e. a night of total sleep deprivation).  
 
Materials and methods 
 
Clinical study 
Clinical sessions were conducted at the Surrey Clinical Research Centre (SCRC) at the 
University of Surrey (UK). Ethical approval was obtained from the University Ethics 
Committee and all procedures were conducted in accordance with the Declaration of 
Helsinki. The experimental protocol of the study conformed to international ethical standards 
(Portaluppi et al., 2010). 
A detailed description of the study protocol and the initial screening phase including 
eligibility criteria have been reported previously (Ackermann et al., 2012). Briefly, study 
eligibility was determined by questionnaires, medical and physical assessment, and analysis 
of blood and urine samples. Exclusion criteria included, but were not limited to, smoking, the 
taking of prescription medication, abnormal blood haematology and testing positive for drugs 
of abuse. Healthy males (n = 15; mean age ± SD: 24 ± 5 yrs), participated in the study, with 
12 participants (23 ± 5 yrs) included in the current study analysis. Written and oral informed 
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consent was obtained and participants were allowed to withdraw at any time. All participant 
information was coded and held in strictest confidence according to the Data Protection Act 
(UK, 1998). 
Participants were required to maintain a strict regular sleep-wake schedule for 7 days prior to 
entering the laboratory, confirmed by activity/light monitors (Actiwatch, CamNtech, 
Cambridge, UK), sleep logs and time-stamped voicemail, which aimed at stabilising the 
circadian clock and ensuring that participants were not sleep deprived. In addition, they were 
required to get at least 15 min of outdoor lighting within 90 min of waking each day. 
Consumption of caffeine, alcohol and medication was prohibited for the final 3 days of this 
baseline period.  
Participants entered the laboratory at 17:00 h on day 1 and remained there until 18.00 h on 
day 4. Overnight periods were spent in individual sleep laboratories, with the adaptation 
(night 1; N1) and baseline (night 2; N2) nights including a normal sleep period (23:00 – 
07:00 h), and total sleep deprivation on the third night (night 3; N3). Polysomnography 
monitoring occurred on nights 2 and 3 to confirm sleep on night 2 and wakefulness on night 
3. Blood samples for gene expression and hormone analyses were collected into PAXgene 
RNA tubes (Qiagen, Crawley, UK) and lithium heparin tubes at hourly intervals for 48 hours 
(from 12:00 h on day 2 to 12:00 h on day 4) using an intravenous catheter and sampling 
through a portal in the wall on night 2 so that sleep was not disturbed. Subjects had a 
recovery sleep from 13:00 – 18:00 h on day 4 before leaving the laboratory. Identical meals 
(breakfast, lunch, dinner, and snack) were eaten by all participants during the study according 
to UK dietary guidelines. Meals were identical in composition on each day of the study. A 
detailed scheme of the study protocol is shown in Figure 1.  
 
Sample analysis 
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Hormone assays 
Radioimmunoassay analysis was performed on hourly plasma samples to determine 
melatonin and cortisol concentrations (Stockgrand Ltd., University of Surrey, UK) as 
described previously (Fraser et al., 1983; Sletten et al., 2009).  
 
RNA isolation, reverse transcription and real-time polymerase chain reaction (qRT-PCR) 
RNA was extracted from leukocytes using the PAXgene 96 Blood RNA kit (PreAnalytiX, 
Hombrechtikon, Switzerland) according to the manufacturer’s instructions. RNA 
concentration was determined by NanoDrop (NanoDrop Technologies, Wilmington, DE, 
USA), and random samples were inspected for RNA integrity using a Bioanalyzer (Agilent 
Technologies, Waldbronn, Germany). Two-hourly samples from 12:00 h on day 2 to 12:00 h 
on day 4 (25 samples per subject) were used for cDNA synthesis using the RevertAid
TM
 H 
Minus First Strand cDNA synthesis kit (Fermentas, St. Leon-Rot, Germany) with random 
hexamer primers as described in the manufacturer’s instructions.  
 
cDNA was subjected to qRT-PCR using the LightCycler 480 SYBR Green I Kit on a 
LightCycler 480 II platform (Roche Diagnostics, Mannheim, Germany). The protocol was as 
follows: 10 min at 95°C, 45 cycles of 95°C, 60°C, and 72°C (10 s each), followed by a 
melting curve step with continuous acquisition from 65 – 97°C. Relative quantification of 
gene expression was performed using the second derivative maximum method (Roche 
Diagnostics) followed by the delta-delta-cycle-threshold (2CT) method as described 
(Ackermann et al., 2007).  
 
Five reference genes (GAPDH, ACTB, HPRT, PPIB, UBC) were tested for suitability using 
NormFinder software (MOMA, Aarhus University Hospital, Aarhus, Denmark) to determine 
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gene stability values and single cosinor analysis (Minors & Waterhouse, 1989) to ensure 
constitutive expression levels. Of these reference genes, ACTB was determined to be the most 
suitable, with a stability value of .017 and an average p value of .5 for diurnal rhythmicity, 
and was therefore used as reference gene in subsequent RT-PCR experiments. Relative 
expression levels of 11 clock genes and the gene coding for Homo sapiens heat shock 70 kDa 
protein 1B (HSPA1B) were determined: PER1, PER2, PER3, CRY1, CRY2, CLOCK, 
BMAL1, REV-ERB, DEC1, RORA, DBP and HSPA1B.  
 
All primers were acquired from Metabion (Metabion, Martinsried, Germany) and tested for 
efficiency and specificity of amplification. Except for the HSPA1B gene, which does not 
contain introns, primers were designed to span at least one exon-exon junction using Primer-
BLAST (http://www.ncbi.nlm.nih.gov/tools/primer-blast/), or were taken from published 
literature (Archer et al., 2008; Kimura et al., 2011; Lavebratt et al., 2010; Visser et al., 2011; 
Wu et al., 2006), and were checked for transcript specificity using the UCSC In-silico PCR 
tool (http://genome.ucsc.edu/). Primer sequences are given in Supplementary Table S1. 
 
Data analysis: 
Dim light melatonin onset (DLMO) was used as a marker of circadian timing and calculated 
for each individual for both the sleep (night 2, N2) and sleep deprivation (night 3, N3) nights 
using the 25%-threshold method as previously described (Sletten et al., 2009). Melatonin and 
cortisol profiles for each individual were subjected to cosinor analysis (Minors & 
Waterhouse, 1989) for determination of amplitude and peak time (acrophase) for the sleep 
and sleep deprivation conditions separately and for the collapsed data (full 48 hours of 
sampling period). Paired Student’s t-tests (two-tailed) were performed to compare melatonin 
and cortisol rhythm parameters during sleep (N2) and sleep deprivation (N3) (DLMO, 
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melatonin and cortisol acrophase and amplitude, and melatonin area under the curve (AUC) 
with a 12 h night-time bin with individual acrophase as midpoint and a 6 h daytime bin as 
control) (GraphPad Prism 5).  
 
Relative gene expression profiles for each individual were z-scored and subjected to cosinor 
analysis (Minors & Waterhouse, 1989) with a 24 h period (for HSPA1B additional analysis 
with a 12 h period was performed, as reported previously in mice (Hughes et al., 2009)) for 
determination of peak time, amplitude, and significance of fit. Cosinor analysis was 
performed separately for each condition and the collapsed dataset as described for the 
hormone analysis. Calculated acrophases for melatonin and PER3 expression on N2 were 
subjected to Spearman correlation. Non-linear curve fitting using a cosine function with a 24 
h period on z-scored normalised gene expression levels was employed to characterise diurnal 
rhythms for each gene (nls function of the stats package of R software version 2.12.0) as 
described recently (Ackermann et al., 2012). This analysis was phase-adjusted individually 
using i) average melatonin peak time and ii) average DLMO on baseline sleep night (N2) 
(two of the 12 participants exhibited a phase-delay in peak melatonin timing compared to the 
other subjects and were excluded for calculation of average peak time and DLMO). Gene 
expression data were phase-adjusted using the calculated time difference between individual 
melatonin peak time/DLMO and average melatonin peak time/DLMO for all downstream 
analysis. Equation for non-linear curve fitting: phase-adjusted normalised z-score = i + 
*cos(2**(TP-t)/24); where TP is the sampling time, i is the individual term for the 
individual i,  is the amplitude and t the peak time of the cosine function. The following null 
hypotheses were tested for significance: 1) the amplitude and 2) peak times were not different 
from zero. Analysis was performed separately for the sleep and sleep deprivation condition, 
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and for the collapsed 48 h dataset. The level of significance was reduced from p < .05 to p < 
.0042 (Bonferroni correction for multiple testing). 
 
Results 
 
Hormone rhythms 
Cortisol 
Individual cortisol profiles exhibited a significant (p < .03) diurnal pattern with peak times in 
the early morning (Supplementary Figure S1; Supplementary Table S2). There were no 
significant differences between the sleep and the sleep deprivation condition for either 
acrophase (p = .4913) or amplitude (p = .1040) (Figure 2). 
 
Melatonin  
Individual melatonin profiles showed a significant (p < .0001) diurnally rhythmic pattern 
with peak times in the second half of the night (Supplementary Figure S2; Supplementary 
Table S3). Compared to the sleep condition, during sleep deprivation, the melatonin 
acrophase was significantly delayed (mean ± SEM: 00.42 ± 00.14 h; p = .0129; Figure 2 top), 
amplitude was significantly increased (29.6 ± 7.7%; p = .0012; Figure 2 bottom) and the 
nocturnal melatonin AUC significantly increased (25.4 ± 4.4%; p = .0003, Supplementary 
Figure S3). By contrast, daytime melatonin levels assessed by AUC did not differ 
significantly between day 2 and day 3 (p = .7408, Supplementary Figure S3). DLMO did not 
differ significantly in timing between N2 (21.08 ± 00.21 h) and N3 (21.38 ± 00.26 h, p = 
.1931, Supplementary Figure S4), but results showed a trend towards significance upon 
excluding the most phase-delayed subject (Figure S2; p = 0.0572).  
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Gene expression levels 
Diurnal rhythmicity in mRNA signatures during the baseline condition was found for most 
but not all candidate genes tested. An illustration of individual profiles for each gene 
investigated is provided in Figure 3, and a summary of the cosinor analysis is given in Table 
1. The most robust rhythms, displaying clear peaks and high amplitude, were detected for 
PER3 and REV-ERB, followed by BMAL1 and PER1. Eight out of the twelve subjects 
showed significant PER3 expression rhythms during the sleep condition (N2), and correlation 
with corresponding melatonin peak times showed a tendency towards significance (p = 0.069; 
n = 8).  HSPA1B expression showed strong 24 h, but not 12 h, rhythmicity. Except for RORA 
and DEC1, at least 3 out of the 12 subjects showed significant rhythmicity in expression 
levels for the 10 remaining genes, and the number of subjects with significant rhythms was 
found to be equal or lower during sleep deprivation compared to the sleep condition. Non-
linear curve fitting revealed significant rhythms in all genes, except DEC1 and CRY1/2, in at 
least one of the three conditions (sleep, sleep deprivation, collapsed 48 h) for data corrected 
to individual circadian time using both DLMO and melatonin peak time. Peak times 
calculated by non-linear curve fitting (Table 2, Supplementary Table S4) were in close 
agreement to the peak times determined using the cosinor method. 
 
High-amplitude rhythms for all conditions (sleep, sleep deprivation, collapsed 48 h) were 
detected for PER1, PER3 and REV-ERB, while for BMAL1 and HSPA1 such high 
amplitudes were only found in the sleep condition. Closer examination revealed that the 
diurnal rhythms in expression levels of BMAL1 and HSPA1B were disrupted by sleep loss, 
exhibiting strongly reduced amplitudes (~70 % and ~50 % reduction for BMAL1 and 
HSPA1B, respectively) and loss of rhythmicity (Table 2). While BMAL1 expression was 
suppressed (total sum z-scores: 15.33 during sleep compared to -12.29 during sleep 
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deprivation), HSPA1B expression was induced, exhibiting elevated baseline levels during 
sleep deprivation (total sum z-scores: -3.46 sleep versus 4.49 sleep deprivation). By contrast, 
other clock genes with high-amplitude diurnal rhythms (e.g. PER1, PER3, REV-ERB) were 
not significantly affected by sleep deprivation. Of the genes with lower amplitude, CRY1, 
corrected to melatonin peak time, showed significant rhythmicity only during the sleep 
condition, with an almost complete loss of amplitude during sleep deprivation (Table 2). In 
addition, for CLOCK and DBP a strong reduction in amplitude during sleep deprivation was 
observed (~40% and ~18%, respectively; Table 2), even though rhythmicity was maintained. 
In general, the amplitudes of the gene expression rhythms in the sleep deprivation condition 
were lower and less often reached statistical significance compared to the sleep condition.  
 
Discussion 
 
This study aimed to address the impact of one night of total sleep deprivation under 
controlled laboratory conditions on both biomarkers of the central circadian pacemaker and 
peripheral oscillators in blood cells.  
Although melatonin is one of the best characterised and reliable markers of human circadian 
phase and widely used in sleep-related studies, there is surprisingly little conclusive 
information regarding the acute effects of sleep deprivation on the amplitude and timing of 
the melatonin rhythm (Salin-Pascual et al., 1988; von Treuer et al., 1996; Zeitzer et al., 2007). 
Our data are in agreement with the work of Salin-Pascual et al. (1988) which showed an 
increase in melatonin levels, but not in cortisol levels, during sleep deprivation, but in 
contrast with the study by von Treuer and colleagues (1996) which reported the opposite 
effects. Further in agreement with the current data, a phase delay in the melatonin rhythm has 
previously been reported after one night of sleep deprivation (Cajochen et al., 2003), and an 
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increase in melatonin levels was found in young subjects during extended wakefulness (up to 
50 h) (Zeitzer et al., 2007). The latter study, however, also described an age-dependent 
difference in melatonin profiles, with young subjects exhibiting reduced and older subjects 
exhibiting elevated melatonin levels during one night of sleep deprivation compared to 
habitual sleep.  
While melatonin peak times were consistently delayed during sleep deprivation in all but the 
two phase-delayed subjects, the DLMO did not consistently change to later times on the sleep 
deprivation night (N3). This finding was predicted as we would not expect the DLMO to 
show the same change as the melatonin acrophase as in the early evening at DLMO the 
subjects were not yet sleep deprived and thus DLMO should be the same on both nights (N2 
and N3). While the current melatonin data showed both, an increase and a phase-delay during 
sleep deprivation, similar changes in cortisol levels were not observed. . Even though we 
cannot fully exclude that the differential responses of melatonin and cortisol to sleep 
deprivation observed in our study are protocol-related,  we hypothesise that the increase in 
melatonin might be interpreted as a direct consequence of the oxidative stress induced by 
sleep loss, and thus might be related to melatonin’s well-reported antioxidative properties 
(Reiter et al., 2000). 
To support our hypothesis on the upregulation of melatonin, the heat shock gene HSPA1B 
was investigated as a representative of genes involved in the oxidative stress response. 
Notably, expression of HSPA1B did not show 12 h rhythmicity, as previously reported for 
mouse tissues (Hughes et al., 2009), but instead strong 24 h rhythmicity during the sleep 
condition. The observed induction of HSPA1B during sleep deprivation is in agreement with 
previous work demonstrating its upregulation in obstructive sleep apnoea and disease-
associated oxidative stress, and enhanced HSPA1B gene expression in several brain regions 
in mice during sleep deprivation (Lavie et al., 2010; Terao et al., 2003). Interestingly, a recent 
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study on changes in the brain transcriptome upon sleep deprivation demonstrated that 
upregulation of HSPA1B in mice remains even if the corticosterone arm of the stress response 
has been eliminated (Mongrain et al., 2010). Thus, our data support a role of HSPA1B in the 
body’s immediate response to (oxidative) stress induced by sleep loss. Furthermore, we have 
recently demonstrated an immediate immune response to sleep deprivation, reflected by 
elevated circulating granulocyte levels, in blood samples obtained from the same laboratory 
study (Ackermann et al., 2012). Together, our data support the view that sleep deprivation 
can be regarded as a strong external stressor and immune challenge (Faraut et al., 2012; 
Mullington et al., 2010). 
 
The clock gene expression data collected in our study are in agreement with previous reports 
concerning the timing of clock gene rhythms in a regulate sleep/wake cycle and the 
proportion of individual significant rhythms for a given gene (see e.g. Archer et al., 2008). 
Our current data, including the in-depth characterization of the expression levels of 11 clock 
genes during normal sleep-wake and under sleep deprivation conditions, suggest that the core 
clock mechanism in peripheral oscillators is compromised under sleep deprivation conditions, 
as clock gene amplitudes were generally found to be lower compared to the sleep condition. 
Strongest effects of condition (sleep, sleep deprivation) were found for the expression of 
BMAL1, and to a lesser extent, CRY1, both considered core clock components (Hastings et 
al., 2003), which were acutely suppressed during sleep deprivation. Notably, other high-
amplitude clock gene rhythms (e.g. PER1, PER3, REV-ERB) remained unaffected by sleep 
deprivation. Our results are in agreement with a study describing diurnal variation of BMAL1 
both under a normal sleep-wake schedule and a night of acute sleep deprivation in light 
conditions (50 lux) (Kavcic et al., 2011). However, in this study a significant diurnal 
variation in PER2 was also reported in the sleep condition, while we found overall 
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rhythmicity for PER1 and PER3, but not for PER2, under both sleep and sleep deprivation 
conditions. By contrast, James et al. (2007) reported comparable 24 h rhythmicity for both 
PER1 and PER2 under sleep/wake and constant routine sleep deprivation conditions, which is 
in line with our data on PER1 and PER3 (James et al., 2007). However, in contrast to the 
current results, a change in BMAL1 peak expression was observed between  sleep deprivation 
and habitual sleep (James et al., 2007), whereas the current study showed no change in 
BMAL1 peak time but in amplitude. It should be noted that the sampling intervals chosen for 
the current study (from 12:00 h on day 2 to 12:00 h on day 4 after the sleep deprivation) must 
be considered a limitation as it might not have revealed the full effect of the sleep 
deprivation.   
Taken together, our data show that one night of sleep deprivation has a significant impact on 
both the melatonin profile and the rhythmic expression of certain clock genes in human 
peripheral leukocytes. Further studies are needed for a better mechanistic understanding of 
the interactions between sleep deprivation, the circadian system, and the potential impact on 
immunity.  
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Tables 
 
Table 1: Single cosinor analysis of gene expression profiles. Given are the numbers of 
subjects (out of 12) with statistically significant rhythms (p < .05) per condition for each of 
the genes investigated, and the average amplitude and acrophase (decimal time) of those 
subjects. 
 
Gene Sleep Deprivation Collapsed Av. Amplitude Av. Acrophase 
PER1 3 3 8 .87 09.55 
PER2 3 3 2 1.09 04.53 
PER3 8 7 8 1.09 04.64 
CRY1 3 2 0 1.08 03.20 
CRY2 5 3 2 1.09 00.07 
BMAL1 6 3 6 .99 17.99 
CLOCK 5 2 2 1.03 22.20 
REV-ERB 7 6 9 1.01 01.57 
RORA 1 2 1 1.21 06.88 
DEC1 0 2 1 .98 06.36 
DBP 3 1 1 1.14 00.87 
HSPA1B 5 1 4 1.00 17.15 
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Table 2: Summary of non-linear curve fitting results. Given are the calculated amplitudes 
and acrophases (decimal time) for the three datasets (sleep, sleep deprivation, collapsed data). 
Calculations for individual phase-adjustment were performed using the average melatonin 
peak time on the baseline sleep night (N2). Bold numbers indicate significance after 
Bonferroni correction for multiple testing (p < .0042). 
 
Gene Condition 
Amplitude 
(peak-adjusted) 
Acrophase 
(peak-adjusted) 
PER1 Sleep .68 08.12 
 Deprivation .69 07.66 
  Collapsed .67 07.99 
PER2 Sleep .26 07.52 
 Deprivation .31 06.39 
  Collapsed .26 06.57 
PER3 Sleep .75 03.52 
 Deprivation .70 04.47 
  Collapsed .73 03.93 
CRY1 Sleep .34 21.62 
 Deprivation .09 07.61 
  Collapsed .16 22.50 
CRY2 Sleep .17 21.33 
 Deprivation .27 06.23 
  Collapsed .11 02.43 
BMAL1 Sleep .75 17.86 
 Deprivation .22 14.12 
  Collapsed .45 17.17 
CLOCK Sleep .46 20.32 
 Deprivation .10 01.75 
  Collapsed .28 21.44 
REV-ERB Sleep .76 23.60 
 Deprivation .49 01.19 
  Collapsed .66 00.23 
RORA Sleep .24 18.98 
 Deprivation .22 22.12 
  Collapsed .25 20.78 
DEC1 Sleep .29 13.27 
 Deprivation .35 08.85 
  Collapsed .21 10.96 
DBP Sleep .34 23.60 
 Deprivation .27 03.76 
  Collapsed .28 01.23 
HSPA1B Sleep .66 16.77 
 Deprivation .32 16.36 
 Collapsed .50 16.63 
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Figure legends 
 
Figure 1: Study protocol. Black bars indicate sleep periods, 0 lux; grey bars, wake periods, 
semi-recumbent position, < 5 lux; white bars, awake and free movement, 100 lux; 
▲controlled meals;  blood sampling period. Reprinted with permission from SLEEP.  
 
Figure 2: Individual cortisol and melatonin acrophase (top) and amplitude (bottom) values 
calculated by cosinor analysis for the 12 study participants during sleep (N2) and sleep 
deprivation (N3). 
 
Figure 3: Individual relative expression levels (n = 12) of HSPA1B and 11 clock genes 
(PER1-3, CRY1, CRY2, CLOCK, BMAL1, REV-ERB, DEC1, RORA and DBP) during the 48 
h sampling protocol including a night of sleep and sleep deprivation. The black bars indicate 
sleep periods, 0 lux; grey bars, wake periods, semi-recumbent position, < 5 lux; white bars, 
awake and free movement, 100 lux. For each gene the normalized z-scored values are plotted 
for each participant. Note the delayed peak times for PER1 in 2 of the subjects, who also 
showed delayed timing of their melatonin rhythms. 
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Supplementary Figure S1: Individual cortisol rhythms 
 
 
Figure S1: Individual cortisol rhythms (n = 12) over the 48 h sampling protocol. The black 
bars indicate sleep periods, 0 lux; grey bars, wake periods, semi-recumbent position, < 5 lux; 
white bars, awake and free movement, 100 lux.  
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Supplementary Figure S2: Individual melatonin rhythms 
 
 
Figure S2: Individual melatonin rhythms (n = 12) over the 48 h sampling protocol. The two 
subjects which are phase-delayed compared to the other participants are highlighted in 
orange/red. The black bars indicate sleep periods, 0 lux; grey bars, wake periods, semi-
recumbent position, < 5 lux; white bars, awake and free movement, 100 lux.  
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Supplementary Figure S3: Melatonin AUC 
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Figure S3: Area under the curve (AUC) as integrated from individual melatonin profiles for 
a 12 h night-time bin (A) and a 6 h daytime bin (B) on day 2/night 2 versus day 3/night 3. 
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Supplementary Figure S4: Melatonin DLMO 
 
 
Figure S4: Calculated dim light melatonin onsets (DLMO) on N2 and N3. One of the 
subjects shows a very late DLMO in the morning hours on both nights. 
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Supplementary Table S1 
Primer sequences and amplicon lengths of all genes investigated, and the reference gene 
ACTB. 
Gene Primer forward (5' → 3') Primer reverse (5' → 3') 
amplicon  
[bp] 
HSPA1B CTGTACCAGGGTGCCGGTGGT   AGTCCCAACAGTCCACCTCAAAGAC   148 
PER1 GGACACTCCTGCGACCAGGTACTG GGCAGAGAGGCCACCACGGAT 126 
PER2 CGCAGGGTGCGCTCGTTTGA GGGCTCTGGAACGAAGCTTTCG 105 
PER3 GGTCGGGCATAAGCCAATG GTGTTTAAATTCTTCCGAGGTCAAA 143 
CRY1 TCCCAGGTTGTAGCAGCAGTGGA TGCCCATGGAGCTTCTTCCTTGC 114 
Cry2 CCTACCTGCGCTTTGGTTGT TGCTGTTCCGCTTCACCTTT 84 
BMAL1 GCCTACTATCAGGCCAGGCTCA AGCCATTGCTGCCTCATCATTAC 149 
CLOCK TTGGCAAAATGTCATGAGCAC TTGCCCCTTAGTCAGGAACCT 78 
REV-ERB GCGGCGATCGCAACCTCTAGT   GTAGGTGATGACGCCACCTGTGTT   115 
DEC1 GCACGGAGACCTACCAGGGATGT CGATGAGCCGGTGCGGCAAT 119 
DBP GCCGGAGGAGCAGAAGGATGAGAAA AAGGCCGCCCGCACCGATAT 120 
RORA GAGGCAAGAGTGCCGTGGTCAA GGTTGAAGAGCTTCTGGCTCCTTC 108 
ACTB TGACCCAGATCATGTTTGAG CGTACAGGGATAGCACAG 74 
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Supplementary Table S2 
Single cosinor analysis of cortisol profiles. Given are amplitude, acrophase (in decimal 
time), p-value and % rhythm for the sleep condition (first 24 h of sampling), the sleep 
deprivation condition (second 24 h of sampling), and the combined dataset (collapsed, 48 h of 
sampling) for the 12 study participants. Note the delayed phase in subjects R29 and R30. 
Subject Condition Amplitude Acrophase P-value % Rhythm   
R04 Sleep 71.22 8.46 .013418 32.4 * 
  Deprivation 119.39 7.91 .000052 59.2 *** 
  Collapsed 96.32 8.20 .000001 46.0 *** 
R06 Sleep 134.10 10.10 .000019 62.8 *** 
  Deprivation 117.17 6.92 .000304 52.1 *** 
  Collapsed 116.13 8.67 .000000 47.3 *** 
R07 Sleep 112.10 8.85 .000063 58.5 *** 
  Deprivation 120.54 8.40 .000022 62.4 *** 
  Collapsed 118.52 8.71 .000000 61.8 *** 
R08 Sleep 109.34 9.69 .000013 65.8 *** 
  Deprivation 111.27 7.52 .000074 59.6 *** 
  Collapsed 105.91 8.59 .000000 55.3 *** 
R10 Sleep 132.67 10.37 .000020 62.6 *** 
  Deprivation 117.06 9.29 .000693 48.4 *** 
  Collapsed 127.76 9.94 .000000 56.2 *** 
R12 Sleep 130.77 9.05 .000503 49.9 *** 
  Deprivation 174.31 8.90 .000015 63.6 *** 
  Collapsed 154.10 9.01 .000000 56.9 *** 
R29 Sleep 114.35 13.03 .000357 51.4 *** 
  Deprivation 103.73 14.93 .001164 45.9 ** 
  Collapsed 104.04 13.97 .000002 44.1 *** 
R30 Sleep 162.81 12.09 .000000 84.7 *** 
  Deprivation 179.10 12.12 .000021 62.4 *** 
  Collapsed 170.16 12.11 .000000 69.4 *** 
R32 Sleep 130.98 7.91 .000002 70.0 *** 
  Deprivation 156.22 8.15 .000000 79.6 *** 
  Collapsed 144.51 8.09 .000000 74.2 *** 
R33 Sleep 103.30 7.87 .030655 27.2 * 
  Deprivation 83.83 7.79 .004386 39.0 ** 
  Collapsed 96.46 8.05 .000107 32.8 *** 
R39 Sleep 87.96 8.45 .032099 26.8 * 
  Deprivation 116.20 9.69 .000012 64.2 *** 
  Collapsed 102.45 9.21 .000009 39.6 *** 
R41 Sleep 72.37 7.81 .002721 41.5 ** 
  Deprivation 122.44 8.62 .000205 53.8 *** 
  Collapsed 98.55 8.41 .000000 47.0 *** 
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Supplementary Table S3 
Single cosinor analysis of melatonin profiles. Given are amplitude, acrophase (in decimal 
time), p-value and % rhythm for the sleep condition (first 24 h of sampling), the sleep 
deprivation condition (second 24 h of sampling), and the combined dataset (collapsed, 48 h of 
sampling) for the 12 study participants. Note the delayed phase in subjects R29 and R30. 
Subject Condition Amplitude Acrophase P-value % Rhythm   
R04 Sleep 21.30 1.97 .000002 70.3 *** 
  Deprivation 27.25 2.71 .000001 73.0 *** 
  Collapsed 24.48 2.35 .000000 69.8 *** 
R06 Sleep 22.36 3.10 .000000 84.2 *** 
  Deprivation 25.25 3.53 .000000 84.3 *** 
  Collapsed 23.77 3.33 .000000 83.1 *** 
R07 Sleep 17.69 1.54 .000027 61.6 *** 
  Deprivation 26.97 1.77 .000000 88.0 *** 
  Collapsed 22.45 1.67 .000000 72.2 *** 
R08 Sleep 7.36 2.38 .000001 72.3 *** 
  Deprivation 6.85 2.87 .000010 66.7 *** 
  Collapsed 7.09 2.62 .000000 69.0 *** 
R10 Sleep 32.19 2.88 .000000 84.3 *** 
  Deprivation 34.92 3.21 .000000 81.0 *** 
  Collapsed 33.57 3.05 .000000 81.9 *** 
R12 Sleep 10.25 3.18 .000021 62.5 *** 
  Deprivation 14.72 3.60 .000000 73.6 *** 
  Collapsed 12.59 3.38 .000000 66.3 *** 
R29 Sleep 16.27 7.64 .000003 68.5 *** 
  Deprivation 20.76 7.58 .000000 73.5 *** 
  Collapsed 18.58 7.64 .000000 69.7 *** 
R30 Sleep 58.72 5.14 .000000 85.7 *** 
  Deprivation 68.54 4.84 .000000 84.8 *** 
  Collapsed 63.43 5.01 .000000 83.6 *** 
R32 Sleep 8.37 1.30 .000000 81.8 *** 
  Deprivation 11.99 1.37 .000000 75.0 *** 
  Collapsed 10.27 1.33 .000000 73.0 *** 
R33 Sleep 18.05 1.22 .000002 69.6 *** 
  Deprivation 21.45 1.69 .000000 78.1 *** 
  Collapsed 19.91 1.46 .000000 73.2 *** 
R39 Sleep 14.38 1.99 .000085 57.3 *** 
  Deprivation 28.03 3.67 .000000 78.5 *** 
  Collapsed 20.86 3.09 .000000 62.5 *** 
R41 Sleep 6.27 2.73 .000001 71.3 *** 
  Deprivation 7.20 3.24 .000011 64.6 *** 
  Collapsed 6.83 2.94 .000000 66.8 *** 
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Supplementary Table S4 
Summary of non-linear curve fitting results. Given are the calculated amplitudes and 
acrophases (decimal time) for the three datasets used (sleep, sleep deprivation, collapsed 
data). Calculations for individual phase-adjustment were performed using the average DLMO 
on N2. Bold numbers indicate significance after Bonferroni correction for multiple testing (p 
< .0042). 
Gene Condition 
Amplitude 
(DLMO-shifted) 
Acrophase 
(DLMO-shifted) 
PER1 Sleep .73 08.17 
 Deprivation .68 07.58 
  Collapsed .69 08.00 
PER2 Sleep .32 07.30 
 Deprivation .29 06.27 
  Collapsed .28 06.47 
PER3 Sleep .78 03.83 
 Deprivation .70 04.42 
  Collapsed .75 04.04 
CRY1 Sleep .30 22.01 
 Deprivation .07 06.40 
  Collapsed .16 22.97 
CRY2 Sleep .12 22.21 
 Deprivation .23 05.87 
  Collapsed .12 02.71 
BMAL1 Sleep .69 17.85 
 Deprivation .17 14.85 
  Collapsed .41 17.41 
CLOCK Sleep .40 20.65 
 Deprivation .14 01.34 
  Collapsed .27 21.94 
REV-ERB Sleep .74 23.85 
 Deprivation .52 01.15 
  Collapsed .66 00.35 
RORA Sleep .22 19.28 
 Deprivation .23 21.96 
  Collapsed .25 20.98 
DEC1 Sleep .24 13.11 
 Deprivation .30 08.46 
  Collapsed .17 10.42 
DBP Sleep .34 00.41 
 Deprivation .28 03.38 
  Collapsed .31 01.53 
HSPA1B Sleep .63 16.79 
 Deprivation .33 16.73 
 Collapsed .49 16.76 
 
 
